0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Hepatology

Buy Now

AMPK-S6K1 Signaling Pathway as a Target for Treating Hepatic Insulin Resistance (Paperback, New) Loot Price: R1,213
Discovery Miles 12 130
AMPK-S6K1 Signaling Pathway as a Target for Treating Hepatic Insulin Resistance (Paperback, New): Sang Geon Kim, Je Cho, Hee...

AMPK-S6K1 Signaling Pathway as a Target for Treating Hepatic Insulin Resistance (Paperback, New)

Sang Geon Kim, Je Cho, Hee Yeon Kay

 (sign in to rate)
Loot Price R1,213 Discovery Miles 12 130 | Repayment Terms: R114 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Hepatic insulin resistance and altered insulin metabolism, as characterised by the desensitisation of hepatic parenchymal cells to insulin, play a role in the pathogenesis of liver disease, particularly resulting in steatosis and steatohepatitis. By the same token, type II diabetic patients are at higher risk for developing liver diseases, including steatosis, hepatitis, cirrhosis, and hepatocellular carcinoma. On the other hand, established liver disease from any cause leads to glucose intolerance and peripheral insulin resistance systemically. The link between insulin resistance and liver pathology reviewed in this book suggests that insulin resistance is closely related with a variety of liver diseases. Recent evidence indicates that the AMP activating protein kinase (AMPK) in conjunction with p70 ribosomal S6 kinase 1 (S6K1) serves as a key signalling pathway regulating insulin-dependent physiological functions; thus, this pathway serves as a target for the therapy of diseases associated with insulin resistance. In this chapter, the regulatory role of the AMPK-S6K1 pathway is discussed in terms of enhancing insulin receptor signalling with insulin receptor substrate-1/2 and phosphatidylinositol phosphate kinase activity, which may contribute to preventing and/or treating insulin resistance in the liver.

General

Imprint: nova science publishers
Country of origin: United States
Release date: 2010
First published: 2010
Authors: Sang Geon Kim • Je Cho • Hee Yeon Kay
Dimensions: 155 x 230 x 5mm (L x W x T)
Format: Paperback
Pages: 59
Edition: New
ISBN-13: 978-1-60876-693-2
Categories: Books > Medicine > Clinical & internal medicine > Hepatology
Promotions
LSN: 1-60876-693-4
Barcode: 9781608766932

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Drug Hepatotoxicity, An Issue of Clinics…
Vinod Rustgi Hardcover R2,133 Discovery Miles 21 330
Advances in Cholestatic Liver Diseases…
Cynthia Levy Hardcover R1,692 Discovery Miles 16 920
Drug-Induced Liver Injury, Volume 85
Anup Ramachandran, Hartmut Jaeschke Hardcover R5,477 Discovery Miles 54 770
Liver Cirrhosis - Debates and Current…
Georgios Tsoulfas Hardcover R3,077 Discovery Miles 30 770
Hepatitis A and Other Associated…
Costin Teodor Streba, Cristin Constantin Vere, … Hardcover R3,067 Discovery Miles 30 670
Liver Research and Clinical Management
Luis Rodrigo Hardcover R3,101 Discovery Miles 31 010
Causes, Prevention and Management of…
Daisy Truman Hardcover R3,279 R2,969 Discovery Miles 29 690
Liver Diseases: Clinical Management
Tucker Banks Hardcover R3,037 R2,752 Discovery Miles 27 520
Diagnosis and Treatment of Liver…
Finley Bush Hardcover R3,292 R2,982 Discovery Miles 29 820
Handbook of Hepatology
Dinah Beck Hardcover R3,167 R2,870 Discovery Miles 28 700
Diagnosis and Management of Chronic…
Heidi Hamlin Hardcover R3,095 R2,810 Discovery Miles 28 100
Nonalcoholic Fatty Liver Disease - An…
Emad Hamdy Gad Hardcover R3,065 Discovery Miles 30 650

See more

Partners